Taken together, these results indicate that inhibiting DNMT1 could suppress the EGFR/STAT3/PD-L1 pathway by inhibiting IGFBP2, thereby inhibiting the development of PCa. The gene discussed is IGFBP2; the disease is posterior cortical atrophy.